Nanoform Finland Oyj (STO: NANOFS)

Market Cap	1.26B
Revenue (ttm)	27.46M
Net Income (ttm)	-261.01M
Shares Out	n/a
EPS (ttm)	-3.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,223
Average Volume	13,302
Open	14.54
Previous Close	14.62
Day's Range	14.24 - 14.84
52-Week Range	12.42 - 37.50
Beta	0.80
RSI	44.43
Earnings Date	Feb 27, 2025

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharmaceutical and biotech industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients, as well as designs and develops nanoformed drug substance. It also offers STARMAP, as a secure online portal to perform large numbers of in-silico CESS experiments The company was founded in 2008 and is headquarte...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 165
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NANOFS

Financial Performance

In 2023, Nanoform Finland Oyj's revenue was 2.57 million, a decrease of -26.41% compared to the previous year's 3.49 million. Losses were -20.76 million, -5.98% less than in 2022.

Financial numbers in EUR